FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

395968009: Substance with beta-1 adrenergic receptor agonist mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3644127014 Selective beta-1 adrenoceptor agonist en Synonym Active Entire term case insensitive SNOMED CT core module
3644130019 Selective beta-1 adrenoceptor stimulant en Synonym Active Entire term case insensitive SNOMED CT core module
3663032011 Substance with beta-1 adrenergic receptor agonist mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3663079011 Substance with beta-1 adrenergic receptor agonist mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module
108328401000001118 Selective beta-1 adrenoceptor stimulants en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with beta-1 adrenergic receptor agonist mechanism of action Is a Substance with beta adrenergic receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Substance with beta-1 adrenergic receptor agonist mechanism of action Has disposition Beta adrenergic receptor agonist false Inferred relationship Existential restriction modifier
Substance with beta-1 adrenergic receptor agonist mechanism of action Has disposition Beta-1 adrenergic receptor agonist true Inferred relationship Existential restriction modifier
Substance with beta-1 adrenergic receptor agonist mechanism of action Is a Substance with adrenergic receptor agonist mechanism of action false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing dobutamine Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Selective beta-1 adrenoceptor stimulants adverse reaction Causative agent True Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier 1
Dobutamine adverse reaction Causative agent False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier 2
Dopexamine adverse reaction Causative agent False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier 2
Selective beta-1 adrenoceptor stimulants allergy Causative agent False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Allergy to dobutamine Causative agent False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Allergy to dopexamine Causative agent False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dobutamine 12.5mg/mL infusion concentrate 20mL vial Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dobutamine 50mg/mL infusion concentrate 5mL ampule Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Product containing beta-1 adrenergic receptor agonist Has active ingredient True Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier 1
Product containing dopexamine Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dobutamine hydrochloride 12.5mg/ml infusion concentrate 20ml vial Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dopexamine hydrochloride Is a True Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dobutamine 12.5mg/mL concentrate for intravenous infusion 20mL ampule Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dopexamine Is a True Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Xamoterol Is a True Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dobutamine Is a True Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Selective beta-1 adrenoceptor stimulants allergy Causative agent False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier 1
Nebivolol hydrochloride Is a False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dobutamine hydrochloride Is a True Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dobutamine hydrochloride 250mg/20mL infusion concentrate - product Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dobutamine hydrochloride 250mg/5mL infusion concentrate - product Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Dobutrex 250mg/20mL infusion concentrate Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier
Posiject 250mg/5mL infusion concentrate Has active ingredient False Substance with beta-1 adrenergic receptor agonist mechanism of action Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start